Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.
Chemotherapy
; 67(3): 142-151, 2022.
Article
in En
| MEDLINE
| ID: mdl-35313303
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Neuroendocrine
/
Small Cell Lung Carcinoma
/
Lung Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Chemotherapy
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: